Article

Reciprocal Inhibition of Immunogenic Performance in Mice of Two Potent DNA Immunogens Targeting HCV Related Liver Cancer

2021-04-01

Abstract excerpt

Chronic HCV infection and associated liver cancer impose a heavy burden on the healthcare system. Direct acting antivirals eliminate HCV, unless it is drug resistant, and partially reverse liver disease, but they cannot cure HCV-related cancer. Possible remedy could be a multi-component immunotherapeutic vaccine targeting both HCV-infected and malignant cells, also those not infected with HCV. To meet this need we...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 394a60b0-3a81-5b92-a27f-dfa44f1dba41
DOI: 10.20944/preprints202104.0020.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Reciprocal Inhibition of Immunogenic Performance in Mice of Two Potent DNA Immunogens Targeting HCV Related Liver CancerDOI 10.20944/preprints202104.0020.v1Read

Double-negative T cells: a promising avenue of adoptive cell therapy in transplant oncologySemantic proximity Read

DNA-based immunization breaks tolerance in a hepatitis C virus transgenic mouse model.Semantic proximity Read

Chimerization of the Anti-Viral CD8+ T Cell Response with A Broad Anti-Tumor T Cell Response Reverses Inhibition of Checkpoint Blockade Therapy by Oncolytic VirotherapySemantic proximity Read

Multidisciplinary approach and reactive immunosuppression for gene therapy-related hepatotoxicitySemantic proximity Read

A heterologous prime/boost vaccination strategy enhances the immunogenicity of therapeutic vaccines for hepatitis C virus.Semantic proximity Read

Sequential administration of the native TERT572 cryptic peptide enhances the immune response initiated by its optimized variant TERT(572Y) in cancer patients.Semantic proximity Read

A multivalent mRNA-LNP therapeutic vaccine with broad cross-genotype immunogenicity elicits clearance of HBV infected hepatocytesSemantic proximity Read

Strong HCV NS3/4a, NS4b, NS5a, NS5b-specific cellular immune responses induced in Rhesus macaques by a novel HCV genotype 1a/1b consensus DNA vaccine.Semantic proximity Read

Epitope-optimized alpha-fetoprotein genetic vaccines prevent carcinogen-induced murine autochthonous hepatocellular carcinomaSemantic proximity Read

Telomerase Expression Related with Poor Immune Response to HCV Core Antigen in Egyptian HCV Patients’ PBMCsSemantic proximity Read

[Immune effects of mutated hepatitis B virus precore-core DNA vaccines in mice].Semantic proximity Read

Generation of a HiBiT-expressing recombinant rat hepacivirus supporting both <i>in vivo</i> and <i>in vitro</i> infectionSemantic proximity Read